Dyne Therapeutics, Inc.
DYN
Revenue
0.00
0.000.00%
-Assets
825.88M
▲303.61M▲58.13%
3 Months ChangeLiabilities
50.69M
▲6.47M▲14.62%
3 Months ChangeFree Cash Flow
-78.73M
▼-31.59M▼-67.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-03
Form 8-K
ID: 0001193125-24-211534
2024-08-12
Form 8-K
ID: 0000950170-24-095537
2024-08-12
Form 10-Q
ID: 0000950170-24-095527
2024-05-24
Form 8-K
ID: 0000950170-24-064700
2024-05-22
Form 8-K
ID: 0001193125-24-144470
2024-05-20
Form 8-K
ID: 0001193125-24-142232
2024-05-02
Form 8-K
ID: 0000950170-24-052142
2024-05-02
Form 10-Q
ID: 0000950170-24-052066
2024-03-25
Form 8-K
ID: 0001193125-24-075932
2024-03-05
Form 8-K
ID: 0000950170-24-025408